Blar i St. Olavs hospital på forfatter "Rannikko, Antti"

Viser treff 1-2 av 2

    • PCASTt/SPCG-17-A randomised trial of active surveillance in prostate cancer: Rationale and design 

      Ahlberg, Mats Steinholtz; Adami, Hans Olov; Beckmann, Kerri; Bertilsson, Helena; Bratt, Ola; Cahill, Declan; Egevad, Lars; Garmo, Hans; Holmberg, Lars; Johansson, Eva; Rannikko, Antti; Van Hemelrijck, Mieke; Jäderling, Fredrik; Wassberg, Cecilia; Åberg, Ulrika W.N.; Bill-Axelson, Anna (Journal article; Peer reviewed, 2019)
      Introduction Overtreatment of localised prostate cancer is substantial despite increased use of active surveillance. No randomised trials help define how to monitor patients or when to initiate treatment with curative ...

    • Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P) 

      Löffeler, Sven; Bertilsson, Helena Maria; Müller, Christoph Rainer; Aas, Kirsti; Haugnes, Hege Sagstuen; Aksnessæther, Bjørg Yksnøy; Pesonen, Maiju; Thon, Kristian; Tandstad, Torgrim; Murtola, Teemu; Poulsen, Mads Hvid Aaberg; Nordstrøm, Tobias; Vigmostad, Maria Nyre; Ottosson, Fredrik; Holmsten, Karin; Christiansen, Ola B.; Slaaen, Marit; Haug, Erik Skaaheim; Storås, Anne Holck; Asphaug, Lars; Rannikko, Antti; Brasso, Klaus (Peer reviewed; Journal article, 2024)
      Background Older men (aged ≥75 years) with high risk, non-metastatic prostate cancer (PCa) are increasingly treated with curative therapy (surgery or radiotherapy). However, it is unclear if curative therapy prolongs ...